Methenolone Enanthate (Primobolan) by CYGNUS PHARMACEUTICAL: An Anabolic Steroid with Moderate Effects

Methenolone Enanthate, also known as Primobolan, was first described in 1960, and Squibb Company began producing the injectable drug in 1962. Methenolone was originally prescribed for muscle loss after operations, infections, long-term illnesses, aggressive therapy with corticoids, or malnutrition. In some cases, it was used to treat osteoporosis and breast cancer. Methenolone was also commonly used to promote weight gain in infants with lower-than-normal weight, without any side effects.

Anabolic Steroid with Weak Androgenic Activity

Methenolone is an anabolic steroid derived from dihydrotestosterone (DHT) with weak androgenic activity and a moderate anabolic effect. A notable characteristic of Methenolone is its ability to firmly bind to androgen receptors, more strongly than testosterone.

Positive Effects on the Immune System

The Methenolone hormone has been shown to have a positive effect on the immune system. In cases of muscle wasting and immune issues, such as those associated with AIDS, Primobolan has proven to be very useful. Although it may not be the only steroid used in such cases, as it doesn’t promote strong mass characteristics, its moderate anabolic nature and immune enhancement make it a top choice.

Explore more about Methenolone Enanthate (Primobolan) by CYGNUS PHARMACEUTICAL and other performance-enhancing products at PrimeGear.store.